Concepedia

Daryl Roitman

DR

Statistics

Publications

5

Citations

258

H-Index

5

Active since

1997

Affiliations

The University of Sydney(Current)

The University of Melbourne

Tufts Medical Center

Princess Margaret Cancer Centre

Tufts University

Daryl Roitman is an author at The University of Sydney specializing in oncology, chemotherapy, and medicine.

Publications per year

1997–2025

5

Publications

5

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial

Jeanne Tie, Yuxuan Wang, Jonathan M. Loree et al. · Nature Medicine · 2025 · 39 citations

Medicine, Oncology, Gastrointestinal Oncology +16

Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin’s lymphoma and Hodgkin’s disease: a clinical and molecular analysis

Rajani Kanteti, KB Miller, McCann Jc et al. · Bone Marrow Transplantation · 1999 · 37 citations

Medicine, Hematology, Oncology +17

‘Relative’ chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma

CI Chen, Daryl Roitman, Richard Tsang et al. · Bone Marrow Transplantation · 2002 · 12 citations

Medicine, Oncology, Chemotherapy +15

A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.

David P. Schenkein, Daryl Roitman, Kenneth B. Miller et al. · PubMed · 1997 · 11 citations

Medicine, Hematology, Oncology +14

1–5 of 5